A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT03601897 · TERMINATED
Trial details
- NCT number
- NCT03601897
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2022-05-23
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.